University of Minnesota - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Minnesota - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Minnesota - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Minnesota - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
40 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Minnesota (UM) is an educational institute that offers research, education and outreach services. The institute offers educational programs in the areas of medicine, social sciences, science and business. It offers under graduate degree, post graduate, masters and research courses. UMs schools and colleges offers courses in the areas of allied health programs, biological sciences, continuing education, dentistry, design, education and human development, extension, food, and agricultural and natural resource sciences.

University of Minnesota - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Targe

  
Source:
Document ID
GDPH51765D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
University of Minnesota, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
University of Minnesota, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
University of Minnesota, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
University of Minnesota, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
University of Minnesota, Medical Devices Deals, 2010 to YTD 201691
University of Minnesota, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
University of Minnesota, Pharmaceuticals &Healthcare, Deal Details1224
  Partnerships121
    Biocept Enters into Research Agreement with University of Minnesota121
    Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement131
    Targazyme Enters into Agreement with University of Minnesota Medical Center141
    Fate Therapeutics Enters into Research Agreement with Regents of the University of Minnesota151
    University of Minnesota Enters Into An Agreement With Mayo Clinic162
    University of Minnesota And Mayo Clinic Enter Into Research Agreement With Karolinska Institutet182
  Licensing Agreements201
    Oxis Biotech Enters into Licensing Agreement with University of Minnesota201
    PlasmaTech Biopharma Enters into Licensing Agreement with University of Minnesota211
    Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota221
    Apogen Biotech Enters into Licensing Agreement with University of Minnesota231
    RedHill Biopharma Enters into Licensing Agreement with University of Minnesota241
    Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota252
    University Of Minnesota Enters Into Licensing Agreement With Vytacera Pharma271
    Ariel Pharma Enters Into Licensing Agreement With University of Minnesota For Tamiasyn281
    Horizon Discovery Enters Into Licensing Agreement With University Of Minnesota291
    University Of Minnesota Enters Into Licensing Agreement With Flagship Biosciences301
    Horizon Discovery Enters Into Licensing Agreement With The University of Minnesota312
    Cellectis Enters Into Licensing Agreement With University Of Minnesota331
    Horizon Discovery Enters Into Licensing Agreement With University of Minnesota341
    Miromatrix Enters Into Licensing Agreement With University of Minnesota351
University of Minnesota - Key Competitors361
Key Employees371
Locations And Subsidiaries382
  Head Office381
  Other Locations &Subsidiaries382
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Minnesota - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Minnesota-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13653>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Minnesota - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Minnesota-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13653>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research